Market Place
Sourcing Support
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
19 May 2025 //
GLOBENEWSWIRE
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Trial
12 May 2025 //
GLOBENEWSWIRE
Radiopharm Theranostics to Join D. Boral Capital Conference
07 May 2025 //
GLOBENEWSWIRE
Radiopharm doses first patient with 18F-RAD101 in U.S. brain meta
28 Apr 2025 //
GLOBENEWSWIRE
RAD202 Data Confirms Positive Tumor Uptake
17 Mar 2025 //
GLOBENEWSWIRE
RAD 101 Successfully Detects Brain Metastases In New Trial
10 Feb 2025 //
GLOBENEWSWIRE
Lantheus Increases to 12.16% shareholding in Radiopharm with $5 M
10 Jan 2025 //
GLOBENEWSWIRE
Radiopharm Partners with Lantheus for Australia Co-Development
30 Dec 2024 //
GLOBENEWSWIRE
RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
20 Dec 2024 //
GLOBENEWSWIRE
Radiopharm Achieves Nasdaq Listing of American Depositary Shares
27 Nov 2024 //
GLOBENEWSWIRE
AtomVie And Radiopharm Partner On Radioantibody for Multiple Solid Tumors
15 Oct 2024 //
PR NEWSWIRE
Deutsche Bank Appointed As Depositary For Radiopharm ADR
19 Sep 2024 //
BUSINESSWIRE
Radiopharm Receives Strategic Investment for up to A$18 million
20 Jun 2024 //
GLOBENEWSWIRE
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody
09 Oct 2023 //
GLOBENEWSWIRE
Radiopharm Expands Supply Agreement With TerThera for Terbium-161 Isotope
24 Aug 2023 //
GLOBENEWSWIRE
Radiopharm Receives FDA Orphan Drug Designation for Trivehexin (RAD 301)
09 May 2023 //
GLOBENEWSWIRE
Radiopharm Enters Into Supply Agreement with TerThera for Terbium-161 Isotope
17 Apr 2023 //
GLOBENEWSWIRE
Radiopharm Invited to Participate in Jefferies Radiopharma Innovation Summit
28 Mar 2023 //
GLOBENEWSWIRE
Dr Ken Herrmann Appointed to RAD Scientific Advisory Board
03 Mar 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics Partners With Next Generation Preclinical Platform
03 Mar 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics Initiates Process for Nasdaq Listing
14 Feb 2023 //
GLOBENEWSWIRE
Radiopharm Theranostics inks pact with NorthStar Medical Radioisotopes supply
27 Oct 2022 //
PHARMABIZ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.